“Formulation and Optimization of Liquisolid Tablet for Improving the Dissolution Profile of Rivaroxaban by Using DoE Approachand Antithrombic Activity”. Journal of Carcinogenesis 23, no. 1 (October 10, 2025): 701–719. Accessed March 18, 2026. https://carcinogenesis.com/index.php/JOC/article/view/1715.